Clinical Trial Update: Lenvatinib in Locally Advanced Invasive Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of lenvatinib for locally advanced invasive thyroid cancer is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• LENVIMA (lenvatinib)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Differentiated Thyroid Cancer, Advanced Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING